SEC Form D private-offering filing

Nasus Pharma Ltd

Name: Nasus Pharma Ltd - new SEC Form D private-offering filing, Tel Aviv
Published: 2026-02-25

A new SEC Form D private-offering notice from Tel Aviv, a $15,000,040 filer-stated offering target in Biotech. The source filing is one click away.

Nasus Pharma Ltd site↗ Verified via SEC Form D

Clinical stage specialty pharmaceutical company developing powder based intranasal drugs for emergency medical conditions such as anaphylaxis

Filed 2026-02-25Filed to raise $15,000,040First money in 2026-02-10Raised so far $15,000,040HQ (as filed) Tel AvivSector Biotech ✓Stage (inferred) EarlyCall status Non-US principal office

Source linked the Form D on EDGAR↗Website verified nasuspharma.com↗Named in the filing 8 executives & directors

Open this row on the live feed →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.